SCHEMBL30474233

SCHEMBL30474233

Cc1ccc(COc2nc3c(cc2I)CCN(C(=O)OC(C)(C)C)C3)c(Cl)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 1/20 0.45
NR1H2 P55055 1/20 0.40
MAPT P10636 2/20 0.37
RAB9A P51151 1/20 0.36
MAPK1 P28482 1/20 0.36
ALDH1A1 P00352 1/20 0.35
MKNK1 Q9BUB5 2/20 0.35
THRB P10828 1/20 0.35
CDC25B P30305 1/20 0.35
MAP3K5 Q99683 2/20 0.34
KDM4A O75164 1/20 0.34
KDM5A P29375 1/20 0.34
KDM2B Q8NHM5 1/20 0.34
KDM4C Q9H3R0 1/20 0.34
KDM5B Q9UGL1 1/20 0.34
PARP1 P09874 1/20 0.34
TNKS2 Q9H2K2 1/20 0.34
PARP2 Q9UGN5 1/20 0.34
TP53 P04637 1/20 0.34
SUV39H2 Q9H5I1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31413147 1.00 ESR2 (0.45) ESR2NR1H2MAPTRAB9AMAPK1
SCHEMBL30474097 0.85 ESR2 (0.44) ESR2NR1H2MAPTMAPK1ALDH1A1
SCHEMBL31413131 0.85 ESR2 (0.42) ESR2NR1H2MAPTMAPK1MKNK1
SCHEMBL30474258 0.85 ESR2 (0.42) ESR2NR1H2MAPTMAPK1MKNK1
SCHEMBL31413089 0.85 ESR2 (0.44) ESR2NR1H2MAPTMAPK1ALDH1A1
SCHEMBL30474113 0.84 ESR2 (0.47) ESR2NR1H2MAPTMAPK1MKNK1
SCHEMBL30474252 0.82 ESR2 (0.43) ESR2NR1H2MAPTMAPK1MKNK1
SCHEMBL31413060 0.82 ESR2 (0.43) ESR2NR1H2MAPTMAPK1MKNK1
SCHEMBL30474260 0.81 ESR2 (0.44) ESR2NR1H2MAPTMAPK1MKNK1
SCHEMBL30474094 0.81 ESR2 (0.48) ESR2NR1H2MAPTRAB9AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250109148-A1 HETEROCYCLIC GLP-1 AGONISTS SHANGHAI SHOUTI BIOTECHNOLOGY CO., LTD. (CN) 2025-04-03 US disclosed
CN-119343339-A Heterocyclic GLP-1 agonists 加舒布鲁姆生物公司 2025-01-21 CN disclosed
EP-4469444-A1 HETEROCYCLIC GLP-1 AGONISTS Gasherbrum Bio, Inc. (US) 2024-12-04 EP disclosed
WO-2023138684-A1 HETEROCYCLIC GLP-1 AGONISTS GASHERBRUM BIO , INC. (US) 2023-07-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250109148-A1 HETEROCYCLIC GLP-1 AGONISTS GLP1R, GIPR, GCGR ESR2 447/4885NR1H2 456/4885MAPT 3323/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.